The IPO Buzz: City Therapeutics (CTY Proposed) Sets Terms for $175 Million IPO
City Therapeutics (CTY Proposed) unveiled its IPO's terms early today – 9.72 million shares at a price range of $17.00 to $19.00 to raise $174.96 million, if priced at the $18.00 mid-point of its range, according to its S-1/A filing dated Oct. 9, 2026. This is a NASDAQ listing. (Please see our IPO Calendar for the pricing date next week.) At pricing, City Therapeutics would have a market cap..
Read more October 9, 2026IPO Calendar
| Company | Symbol proposed | Shares (Millions) | Est. $ Volume | Expected to Trade | SCOOP Rating | Rating Change |
|---|---|---|---|---|---|---|
| Retension Pharmaceuticals | RTSN | 3.8 | $ 45.0 mil | 10/9/2026 Priced | S/O | S/O |
| TRex Bio, Inc. | TRXB | 8.3 | $ 116.6 mil | 10/9/2026 Priced | S/O | S/O |
| Iambic Therapeutics | IAM | 9.4 | $ 150.0 mil | 10/15/2026 Thursday | S/O | S/O |
Last 100 IPOs - October 8, 2026
| Number of IPOs priced : | 100 |
| Number Up: | 40 |
| Number Down: | 59 |
| Number Unchanged: | 1 |
| Percentage Change From Issue Price: | 0.04% |
| Percentage Change for The Nasdaq Composite | 35.22% |
2026 IPO Scorecard - October 8, 2026
| Number of IPOs priced (Excluding 152 units) : | 125 |
| Number Up: | 47 |
| Number Down: | 77 |
| Number Unchanged: | 1 |
| Total Return From Issue Price: | -0.82% |
| The Nasdaq Composite Index YTD % Change | 35.22% |